Abstract: SA-OR034
Bridging Gaps in Kidney Care: A Pilot Trial of ImPart-Multi for Black Patients with CKD and Comorbidities
Session Information
- Diversity and Equity in Kidney Health: Research and Cases
November 08, 2025 | Location: Room 361A, Convention Center
Abstract Time: 05:30 PM - 05:40 PM
Category: Diversity and Equity in Kidney Health
- 900 Diversity and Equity in Kidney Health
Authors
- Gazaway, Shena, The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Gutierrez, Orlando M., The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
- Wells, Rachel D, The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Lyas, Clare Nichols, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
- Cole, Alicia S., The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Martinez, Isaac, The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Nix Parker, Tamara M., The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Armstrong, Margaret, The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
- Dionne-Odom, James N., The University of Alabama at Birmingham School of Nursing, Birmingham, Alabama, United States
Background
In the concurrent management of chronic kidney disease (CKD) and chronic metabolic conditions (such as hypertension [HTN] or diabetes), it has been found that Black patients remain unaware of their advancing kidney illness risks. We developed ImPart-Multi (Improving Decision Partnership) for these high-risk individuals to improve their ability to engage in health-related decision-making.
Methods
Utilizing a community-engaged approach, a pilot randomized trial assessed ImPart-Multi's feasibility, acceptability, and preliminary efficacy in stage 3B/4 CKD patients with concurrent diagnosis of HTN or diabetes and their care partners. From 10/2023 - 10/2024, dyads were randomized into four groups: basic communication skills, social support effectiveness, combination, and wait-listed. Care partners did not receive sessions but completed data collection only. Outcomes (Decision Conflict Scale, Social Support Effectiveness Scale, Dyadic Coping Inventory, KDQOL-36, Hospital Anxiety and Distress Scale, and the PROMIS-10) were collected at baseline and 12 weeks. Paired sample t-tests were conducted to detect differences. Acceptability interviews were conducted and analyzed.
Results
11 dyads (22 participants) were randomized. Regarding feasibility, 73% completed assigned activities, including data collection. Mean scores for decision conflict decreased, indicating improved perception of conflict when making decisions, and dyadic coping means improved, indicating improved coping. These findings were not statistically significant (see figure 1). ImPart-MULTI was described as informative, helpful, and an intervention that could be useful for others.
Conclusion
Results demonstrate that implementing ImPart-Multi is feasible and acceptable, potentially decreasing decision conflict and improving dyadic coping. These findings and feedback from our community advisory board will help us refine ImPart-Multi for a fully powered R01 optimization trial.
Funding
- Other NIH Support